Regular Article
Pharmacology of systemic analgesics

https://doi.org/10.1053/bean.2002.0262Get rights and content

Abstract

Systemic administration of analgesic drugs is still the most widely used method for providing pain relief in acute painful situations. Opioids may be selected on the basis of their physicochemical characteristics and their diffusion index to the brain. But in clinical practice, their very steep concentration–analgesic effect relationship remains a critical aspect of opioid therapy. Thus, small fluctuations in plasma concentrations of opioids may lead to profound fluctuations in analgesic effect when their plasma and effect-site concentrations are near the minimum effective analgesic concentration (MEAC). Combining drugs acting on different mechanisms of nociceptive modulation offers benefits from additive/synergistic effects and will decrease the incidence of their adverse effects. Evidence-based reviews showed that effective pain relief using non-opioid analgesics relied on paracetamol supplemented with non-steroidal anti-inflammatory drugs (NSAIDs). The role of COX-2 selective inhibitors (CSIs) in acute pain relief still requires further evaluation. NSAIDs, CSIs and paracetamol share the property of morphine sparing in situations of severe (post-operative) pain. CSIs may be beneficial in patients in whom post-operative bleeding is a major surgical risk as the effects of NSAIDs on coagulation may last for days. Finally, low-dose ketamine infusions remain a worthwhile addition to opioid therapy. Analgesic concentrations of ketamine are 1/5th to 1/10th the anaesthetic concentration and exert significant inhibition on N–methyl–d-aspartate (NMDA) receptor activation.

References (69)

  • TJ Coderre et al.

    Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence

    Pain

    (1993)
  • PK Eide et al.

    Continuous subcutaneous administration of the N -methyl- D -aspartic acid (NMDA) receptor antagonist ketamine in the treatment of postherpetic neuralgia

    Pain

    (1995)
  • KM Park et al.

    Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects

    Pain

    (1995)
  • S Ilkjaer et al.

    Effect of systemic N -methyl- D -aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans

    British Journal of Anaesthesia

    (1996)
  • T Warncke et al.

    Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo

    Pain

    (1997)
  • M De Kock et al.

    Balanced analgesia in the perioperative period: is there a place for ketamine?

    Pain

    (2001)
  • M Backonja et al.

    Response of chronic neuropathic pain syndromes to ketamine: a preliminary study

    Pain

    (1994)
  • F Aubrun et al.

    Postoperative titration of intravenous morphine in the elderly patient

    Anesthesiology

    (2002)
  • A Tamsen et al.

    Patient-controlled analgesic therapy. Part II. Individual analgesic demand and analgesic plasma concentrations of pethidine in postoperative pain

    Clinical Pharmacokinetics

    (1982)
  • RK Portenoy et al.

    The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function

    Clinical Pharmacology and Therapeutics

    (1992)
  • GK Gourlay et al.

    Postoperative pain control with methadone: influence of supplementary methadone doses and blood-concentration response relationships

    Anesthesiology

    (1984)
  • L Groshow et al.

    Does intravenous methadone provide longer lasting analgesia than intravenous morphine? A randomized double-blind study

    Pain

    (1989)
  • GK Gourlay et al.

    Fentanyl blood concentration – analgesic response relationship in the treatment of postoperative pain

    Anesthesia and Analgesia

    (1988)
  • AG Johnson et al.

    The problems and pitfalls of NSAID therapy in the elderly (Part 1)

    Drugs & Aging

    (1991)
  • CR Lee et al.

    Tramadol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute and chronic pain states

    Drugs

    (1993)
  • RB Raffa et al.

    Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an ‘atypical’ opioid analgesic

    Journal of Pharmacology and Experimental Therapeutics

    (1992)
  • KA Lehmann

    Tramadol for the management of acute pain

    Drugs

    (1994)
  • CJ Woolf et al.

    Neuronal plasticity: increasing the gain in pain

    Science

    (2000)
  • R Velegapudi et al.

    Pharmacokinetic pharmacodynamic models in analgesic study design

    Advances in Pain Research and Therapy

    (1991)
  • L Paalzow et al.

    The activity of diflunisal and dextropropoxyphene on experimental pain in man: relationships between plasma levels and analgesia

  • EM Laska et al.

    The correlation between blood levels of ibuprofen and clinical analgesic response

    Clinical Pharmacology and Therapeutics

    (1986)
  • H Kehlet et al.

    The value of multimodal or ‘balanced analgesia’ in postoperative pain treatment

    Anesthesia and Analgesia

    (1993)
  • G Engelhardt et al.

    Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new nonsteroidal anti-inflammatory agent with favourable gastrointestinal tolerance

    Inflammation Research

    (1995)
  • I Tigerstedt et al.

    The efficacy of intravenous indomethacin in prevention of postoperative pain

    Acta Anaesthesiologica Scandinavica

    (1991)
  • Cited by (0)

    *

    Author to whom all correspondence should be addressed.

    View full text